Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Tobii AB in connection with a directed share issue
Mandate

Vinge has advised Tobii AB (publ) in connection with a directed share issue

November 08, 2021 Capital Markets and Public M&A

Vinge has advised Tobii AB in connection with a directed share issue whereby the company receives approximately SEK 300 million in gross issue proceeds.

The share issue was carried out as an accelerated book building process and directed to selected Swedish and international institutional investors. Tobii intends to use the issue proceeds to finance the acquisition of Phasya, to finance the acquisition of Acapela Group and to strengthen the balance sheet in both Tobii and Tobii Dynavox in connection with the separate listing of Tobii Dynavox and thereby create headroom for further acquisitions and investments.

Vinge’s team has consisted of Jesper Schönbeck, Amanda Knutsson, Joel Magnusson and David Bokliden.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025